Xeris Biopharma Holdings, Inc. (XERS) revenue

Revenue · fiscal 2025
$291.85M

Xeris Biopharma Holdings, Inc. (XERS) reported revenue of $291.85M in fiscal 2025 (the year ended December 31, 2025). That is 43.7% higher than the $203.07M of fiscal 2024. Figures as of 18 Nov 2026, 12:37 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$291.85M
Change on fiscal 2024
+43.7%
Growth, 5 years
+70.7% a year
Highest on record
$291.85Mfiscal 2025
Lowest on record
$20.16Mfiscal 2020
Fiscal years on record
62020–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Xeris Biopharma Holdings, Inc. revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 70.7% a year. Across the 6 fiscal years on record (2020–2025), the highest was $291.85M in fiscal 2025 and the lowest $20.16M in fiscal 2020.

History · 6 fiscal years

Revenue by fiscal year

Xeris Biopharma Holdings, Inc. revenue, year by year

Xeris Biopharma Holdings, Inc. (XERS) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$291.85M 43.7% up
2024$203.07M 23.9% up
2023$163.91M 48.7% up
2022$110.25M 122.3% up
2021$49.59M 146.0% up
2020$20.16M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

More on XERS

Xeris Biopharma Holdings, Inc., figure by figure

Xeris Biopharma Holdings, Inc. (XERS) overview: price, valuation and scorecard

Xeris Biopharma Holdings, Inc. revenue: questions and answers

What is Xeris Biopharma Holdings, Inc.'s revenue?

Xeris Biopharma Holdings, Inc. (XERS) reported revenue of $291.85M in fiscal 2025 (the year ended December 31, 2025). That is 43.7% higher than the $203.07M of fiscal 2024.

What is the growth rate of Xeris Biopharma Holdings, Inc.'s revenue?

Over the five fiscal years to 2025 revenue grew at a compound 70.7% a year.

What are the highest and lowest revenue figures on record for Xeris Biopharma Holdings, Inc.?

Across the 6 fiscal years on record (2020–2025), the highest was $291.85M in fiscal 2025 and the lowest $20.16M in fiscal 2020.

How is Xeris Biopharma Holdings, Inc.'s revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Xeris Biopharma Holdings, Inc. it is on record here for 6 fiscal years, 2020 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Xeris Biopharma Holdings, Inc. (XERS) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/XERS/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.